Table 1. Clinical features and outcomes of anti-tuberculous treatment in study group.
| Pt. no. | Age at diagnosis | Sex | Country of birth | Description of uveitis | Type | Eye | ? TB | TB contact | CXR | TST | G-IFN | Start dose of steroid | Steroid Rx duration | R VA at presentation | L VA at presentation | R VA at 12 m | L VA at 12 m | Final diagnosis |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 26 | M | India | REV | NGR | B | Smear +ve pulm TB | N | Active | Not done | Not done | 60 | 24 | 6/5 | 6/5 | 6/36 | 6/5 | TB uveitis |
| 2 | 45 | F | India | CAU | GRA | B | N | N | Clear | ++ | Not done | 6/6 | 6/6 | 6/6 | 6/6 | TB uveitis | ||
| 3 | 53 | M | Pakistan | CPU | NGR | B | N | N | Clear | ++ | Positive | 60 | 8 | 6/12 | 2/36 | 6/60 | 2/36 | TB uveitis |
| 4 | 42 | F | UK | GEO | NGR | B | N | Y | Old focus | ++ | Not done | 3/60 | 6/9 | 3/60 | 6/6 | Non TB- serpiginous | ||
| 5 | 33 | F | Pakistan | EAL | NGR | B | N | N | Clear | ++ | Not done | 40 | 6 | 6/12 | CF | 6/6 | CF | TB uveitis |
| 6 | 18 | F | UK | CPU | NGR | B | N | Y | Clear | + | Positive | 40 | 12 | 6/9 | 6/9 | 6/12 | 6/6 | Unknown |
| 7 | 45 | F | India | INT | NGR | R | N | Y | Clear | ++ | Not done | 3/60 | 6/9 | 6/36 | 6/6 | Unknown | ||
| 8 | 3 | F | UK | CPU | NGR | B | N | Y | Hilar nodes | ++ | Not done | 6/9 | 6/6 | 6/9 | 6/9 | Unknown | ||
| 9 | 38 | M | India | MCH | NGR | B | N | N | Clear | ++ | Not done | 60 | 7 | 6/6 | 6/24 | 6/5 | 6/5 | TB uveitis |
| 10 | 35 | F | Senegal | FCH | GRA | B | Old lung | N | Old focus | Not done | Not done | 30 | 7 | 6/4 | 6/9 | 6/5 | 6/9 | TB uveitis |
| 11 | 28 | M | UK | INT | NGR | B | N | Y | Clear | ++ | Not done | 80 | 8 | 6/9 | 6/9 | 6/9 | 6/9 | Sarcoidosis |
| 12 | 50 | F | India | CPU | NGR | B | N | Y | Clear | ++ | Not done | 60 | 12 | 6/24 | 6/18 | 6/18 | 6/18 | TB uveitis |
| 13 | 75 | F | UK | CPU | NGR | B | Old lung | N | Old focus | Not done | Not done | 80 | 13 | 6/36 | 6/36 | 6/9 | 6/12 | TB uveitis |
| 14 | 35 | F | India | CPU | GRA | B | N | Y | Clear | ++ | Not done | 60 | 8 | 6/18 | 6/60 | 6/9 | 6/60 | TB uveitis |
| 15 | 46 | M | India | INT | NGR | R | Smear + pulm TB | N | Active | ++ | Not done | 80 | 10 | 6/18 | 6/4 | 6/6 | 6/4 | TB uveitis |
| 16 | 60 | F | Pakistan | CAU | NGR | B | N | Y | Clear | ++ | Not done | 40 | 12 | 6/18 | 6/18 | 6/9 | 6/9 | TB uveitis |
| 17 | 55 | F | UK | CPU | GRA | L | N | Y | Clear | ++ | Positive | 80 | 12 | 6/6 | 6/36 | 6/6 | Hm | TB uveitis |
| 18 | 19 | F | Pakistan | CPU | GRA | R | N | N | Clear | ++ | Not done | 60 | 5 | 6/60 | 6/6 | NPL | 6/6 | TB uveitis |
| 19 | 32 | M | Gambia | CPU | GRA | R | N | Y | Clear | ++ | Positive | 6/12 | 6/6 | 6/6 | 6/6 | Unknown | ||
| 20 | 35 | M | Sudan | MCH | NGR | B | N | Y | Clear | ++ | Not done | 40 | 9 | 6/5 | 6/9 | 6/5 | 6/5 | TB uveitis |
| 21 | 23 | M | Pakistan | EAL | NGR | B | N | Y | Clear | ++ | Not done | 60 | 12 | 6/5 | 6/36 | 6/6 | 6/6 | TB uveitis |
| 22 | 46 | F | Bangladesh | INT | NGR | L | N | N | Old focus | ++ | Not done | 6/4 | 6/9 | 6/6 | 6/6 | TB uveitis | ||
| 23 | 19 | F | India | APU | GRA | B | N | N | Clear | ++ | Not done | 40 | 6 | 6/12 | 6/12 | 6/6 | 6/9 | TB uveitis |
| 24 | 27 | M | UK | CPU | NGR | B | N | N | Clear | ++ | Not done | 6/60 | 6/24 | 1/60 | 6/6 | TB uveitis | ||
| 25 | 32 | M | India | AAU | NGR | B | Spine | N | Clear | Not done | Not done | 6/6 | 6/36 | 6/6 | 6/18 | Unknown | ||
| 26 | 23 | M | India | EAL | NGR | B | N | Y | Clear | ++ | Not done | 60 | 5 | 6/6 | 6/9 | 6/6 | 6/6 | TB uveitis |
| 27 | 34 | F | Gambia | INT | NGR | B | N | Y | Hilar nodes | ++ | Not done | 60 | 7 | 6/9 | 6/9 | 6/6 | 6/6 | Sarcoidosis |
Abbreviations: APU, acute panuveitis; AAU, acute anterior uveitis; B, bilateral; CAU, chronic anterior uveitis; CPU, chronic panuveitis; CXR, chest X-ray; FCH, focal choroiditis; GEO, geographic choroiditis; G-IFN, gamma-interferon testing GRA, granulomatous; INT, intermediate uveitis; L, left; MCH, multifocal choroiditis; N, no; NGR, nongranulomatous; R, right; REV, retinal vasculitis; TST, tuberculin skin test +, positive; ++, strongly positive; Y, yes.